Biologics
Antibodies, peptides, vaccines, biosimilars, oligonucleotides, exosomes, ADCs
Read More:
An interactive community working to identify and overcome challenges to translation of biologics, developing new biologic drugs or with an interest in learning more about therapeutic antibodies, peptides and vaccines as well as, biosimilars, oligonucleotides, exosomes, antibody drug conjugates and protein therapeutics.
Interdisciplinary Biologics interest group community will engage in:
1) Sharing knowledge, expertise and latest developments in biopharmaceuticals.
2) Working together to identify and overcome challenges to translation of biologics
3) Actively seeking and building external partnerships to drive translation of biologics.
Join here.
